Fresenius Group Overview
- The Health Care Group
-
Stories
-
![]()
Growing up with parenteral nutrition
-
![]()
Paul, the four-legged therapist
-
![]()
The History of Dialysis
-
![]()
’Remain true to your ideals’
-
![]()
Serving patients in Swaziland
-
![]()
Using protons to take on cancer
-
![]()
A little heart at the center of a complex surgery
-
![]()
On duty in disaster zones
-
![]()
More ‘Quality of Life’ in clinics
-
![]()
Ready to help the littlest ones
-
![]()
"I want to help others, so they won’t give up"
-
![]()
From a local pharmacy to a global corporation
-
- Investors
-
Media
![]()
Contact
Matthias Link
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com - Careers
Growing up with parenteral nutrition
Paul, the four-legged therapist
The History of Dialysis
’Remain true to your ideals’
Serving patients in Swaziland
Using protons to take on cancer
A little heart at the center of a complex surgery
On duty in disaster zones
More ‘Quality of Life’ in clinics
Ready to help the littlest ones
"I want to help others, so they won’t give up"
From a local pharmacy to a global corporationMedia
Corporate Communications
Here you can find a variety of information:
- Press releases and Brief news
- Key dates for journalists
- Pictures, videos, audio files, press kits and other documents
- Social media channels
- Personal contacts
Our Corporate Communications team can be reached at pr-fre@fresenius.com.
“A pharmacy today? We need to expand it or add something new to it.” (Dr. Eduard Fresenius, Founder, 1912)
-
![]()
Import (ICS)May 02, 2019 - 01:30 PM | Bad Homburg, Germany
Conference Call Q1 2019, Fresenius
News
- Brief News
Fresenius Helios becomes medical partner at Rafa Nadal Academy
Quirónsalud, the Spanish hospitals unit of Fresenius Helios, has become the Rafa Nadal Academy’s official medical partner. The sports academy of Spain’s Rafael Nadal (nickname “Rafa”), a top international tennis player with 17 Grand Slam tournament victories, offers regular schooling combined with special athletic training for promising young tennis players. As medical partner, Quirónsalud will take responsibility for the athletes’ healthcare, from nutritional advice through to medical treatment.
April 23, 2019Fresenius Helios
Brief NewsFresenius Kabi receives European Commission approval for adalimumab biosimilar IDACIO®
The European Commission (EC) granted Fresenius Kabi the marketing authorization for IDACIO®, an adalimumab biosimilar, for all indications of the reference medicine. With this EC approval, IDACIO® is the first approved molecule of the Fresenius Kabi biosimilars portfolio.
April 03, 2019Fresenius Kabi
-
![]()
![]()
- Brief News
Fresenius Helios and Marburger Bund agree on collective labor agreement
Helios Germany and the doctors' union Marburger Bund have agreed on a collective labor agreement for about 5,400 physicians in 34 Helios hospitals. It applies to the hospitals included in the Helios Group collective labor agreement. With effect from 1 January 2019, the base salary will increase by 2.5 percent. A further increase of 2.5 percent will follow on January 1, 2020. Salaries will thus increase by a total of 5 percent. This is in line with Fresenius Group's expectations.
March 19, 2019Fresenius Helios
Brief NewsFresenius Helios holds topping-out ceremony for new hospital building in Wiesbaden
Fresenius Helios held the topping-out ceremony today for the new main building at Helios HSK hospital in the German city of Wiesbaden, near Frankfurt. The seven-story structure, with almost 100,000 square meters (about 1 million square feet) of floor space, is being erected beside the existing clinic. It will have 22 operating rooms, about 1,000 beds, and a design that significantly reduces distances and waiting times for patients. Helios is investing about €200 million in the new building, while the state of Hesse is contributing €68 million. Completion is scheduled for 2021.
March 15, 2019Fresenius Helios
-
![]()
![]()
-
![]()
![]()
-
![]()
Brief NewsFresenius Kabi receives positive CHMP opinion for MSB11022, a biosimilar candidate of adalimumab
Fresenius Kabi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion, recommending marketing authorization for MSB11022 a biosimilar candidate of Humira® (adalimumab)*. The European Commission (EC) will now decide on the approval of MSB11022 which is expected in Q2/ 2019.
*Humira® is a registered trademark of AbbVie Biotechnology Ltd.February 01, 2019Fresenius Kabi
-
![]()
![]()
- Brief News
Fresenius Vamed adds new resort to network in Austria
VAMED Vitality World has taken over operation of a health resort in Austria’s Styria state. Operating under the new name of Spa Resort Styria in the town of Bad Waltersdorf, near Graz, the resort will offer health tourism for adults. Fresenius Vamed is the market leader in Austria, with about 3.2 million annual visitors to the company’s eight thermal spas and health resorts.
January 14, 2019Fresenius Vamed
Fresenius successfully places €1.0 billion in notes
January 10, 2019Fresenius
-
![]()
Brief NewsFresenius wins award for compensatory time account calculator
Der Gesundheitskonzern Fresenius ist für seinen Langzeitkonto-Rechner mit dem „HR Excellence Award 2018“ in der Kategorie „Compensation & Benefits“ ausgezeichnet worden. Der Langzeitkonto-Rechner bietet den Mitarbeitern schnell und transparent Informationen über eingebrachte Beiträge, Auszeiten für die persönliche Weiterbildung oder die Pflege von Angehörigen sowie einen möglichen Vorruhestand. Mit den „HR Excellence Awards“ prämiert das Magazin „Human Resources Manager“ seit 2012 herausragende Projekte im Personalmanagement.
December 14, 2018Fresenius
-
![]()
Brief NewsPWC proposed as auditor for 2020
The Supervisory Board of Fresenius SE & Co. KGaA has decided to propose PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft as the auditor for the financial year 2020. The shareholders will decide on the appointment at the Annual General Meeting in 2020. New regulations provide for a regular rotation of the auditor, so Fresenius was not able to extend the existing mandate of KPMG AG Wirtschaftsprüfungsgesellschaft.
December 10, 2018Fresenius
-
![]()
![]()
-
![]()
![]()
- Brief News
Fresenius Kabi receives FDA Drug Shortage Assistance Award
Fresenius Kabi has received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration (FDA). The FDA recognized the role Fresenius Kabi played in helping mitigate a shortage of IV saline, specifically Sodium Chloride Injection USP, 0.9% in bags. The shortage was caused last year by supply disruptions at manufacturers affected by Hurricane Maria. The hurricane devastated Puerto Rico, where many companies produce medicines for U.S. hospitals.
December 03, 2018Fresenius Kabi
Brief NewsFresenius Vamed wins awards for spa and wellness facilities
VAMED Vitality World has been named the “World’s Best Thermal Spa & Medical Wellness Operator 2018” at the World Spa Awards. Four VAMED Vitality World facilities – Geinberg5 Private Villas, Aqua Dome Therme Längenfeld, Therme Laa Hotel & Spa, all in Austria, and Aquaworld Resort Budapest in the Hungarian capital – also won in their individual categories. VAMED Vitality World, part of Fresenius Vamed, operates a total of nine spa and health resorts in Austria and Hungary.
November 26, 2018Fresenius Vamed
- Brief News
Fresenius training programs among the best in Germany
A recent study places Fresenius among the top 500 companies in terms of career training programs in Germany. Criteria used for judgement were the quality of supervision, in-house training, company engagement, success rate and innovative teaching methods. The companies were rated by the business magazine Capital and the internet portal, ausbildung.de. Fresenius received a best possible five-star rating for its on-the-job training and dual-studies, a combination of theory and on-the-job training, programs. The company trains more than 4,000 apprentices and dual-studies interns.
November 19, 2018Fresenius
![]()
-
![]()
Brief NewsFresenius Helios acquires private hospital operator in Colombia, expanding presence in Latin America
Quirónsalud, the Spanish hospital group that is part of Fresenius Helios, has acquired Clínica Medellín and entered the attractive private hospital market in Colombia. Clínica Medellín operates two centrally located hospitals in Medellín, a major city of 2.5 million people. The two facilities have a total of about 185 beds. The total investment for Clínica Medellín is more than €50 million. Following Quirónsalud's entry into Peru last year, this is another step in strengthening the company’s presence in Latin America’s growing and consolidating hospital markets. Fresenius Helios expects the transaction to close in Q1 2019, pending anti-trust and regulatory clearance.
October 30, 2018Fresenius Helios
Contact
Do you have other questions or need any more information?
Your contact:
Matthias Link
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Social Media
-
Gehe zu Facebook
I hereby express my consent to the processing of my personal data for the usage of the social Feeds according to paragraph 4 of the "Privacy Policy and Declaration of Consent".
I consent -
Gehe zu Twitter
I hereby express my consent to the processing of my personal data for the usage of the social Feeds according to paragraph 4 of the "Privacy Policy and Declaration of Consent".
I consent -
Gehe zu Youtube
- Gehe zu LinkedIn
- Gehe zu Xing
Contact us
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com
Contact
